Your browser doesn't support javascript.
loading
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen, Sandra; Roy, Jean; Lachance, Silvy; Delisle, Jean-Sébastien; Marinier, Anne; Busque, Lambert; Roy, Denis-Claude; Barabé, Frédéric; Ahmad, Imran; Bambace, Nadia; Bernard, Léa; Kiss, Thomas; Bouchard, Philippe; Caudrelier, Pierre; Landais, Sévérine; Larochelle, Fannie; Chagraoui, Jalila; Lehnertz, Bernhard; Corneau, Sophie; Tomellini, Elisa; van Kampen, Jeroen J A; Cornelissen, Jan J; Dumont-Lagacé, Maude; Tanguay, Mégane; Li, Qi; Lemieux, Sébastien; Zandstra, Peter W; Sauvageau, Guy.
Afiliação
  • Cohen S; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada. Electronic address: sandra.cohen@umontreal.ca.
  • Roy J; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Lachance S; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Delisle JS; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Marinier A; Drug Discovery Unit, Montreal, QC, Canada; ExCellThera, Montreal, QC, Canada.
  • Busque L; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Roy DC; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Barabé F; Division of Hematology, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), Quebec, QC, Canada; Department of Medicine, Université Laval, Quebec, QC, Canada.
  • Ahmad I; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Bambace N; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Bernard L; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Kiss T; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Bouchard P; Department of Pharmacy, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada.
  • Caudrelier P; ExCellThera, Montreal, QC, Canada.
  • Landais S; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada.
  • Larochelle F; Center of Excellence for Cellular Therapy, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada.
  • Chagraoui J; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.
  • Lehnertz B; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.
  • Corneau S; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.
  • Tomellini E; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.
  • van Kampen JJA; Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Cornelissen JJ; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Dumont-Lagacé M; ExCellThera, Montreal, QC, Canada.
  • Tanguay M; Department of Medicine, Montreal, QC, Canada; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.
  • Li Q; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada.
  • Lemieux S; Molecular Genetics of Stem Cells Laboratory, and Department of Biochemistry and Molecular Medicine, Montreal, QC, Canada.
  • Zandstra PW; ExCellThera, Montreal, QC, Canada; School of Biomedical Engineering and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
  • Sauvageau G; Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; Department of Medicine, Montreal, QC, Canada; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada; ExCellThera, Montreal, QC, Canada.
Lancet Haematol ; 7(2): e134-e145, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31704264

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Células-Tronco Hematopoéticas / Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Indóis Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged / Newborn Idioma: En Revista: Lancet Haematol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Células-Tronco Hematopoéticas / Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Indóis Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged / Newborn Idioma: En Revista: Lancet Haematol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido